A cell surface marker gene transferred with a retroviral vector into CD34+ cord blood cells is expressed by their T-cell progeny in the SCID-hu thymus

Blood

Volumn 88, Issue 1, 1996, Pages 107-113

  Champseix, Catherine ^b   Maréchal, Valérie ^b   Khazaal, Ibrahim ^b   Schwartz, Olivier ^b   Fournier, Sylvie ^b   Schlegel, Nicole ^b   Dranoff, Glen ^b   Danos, Olivier ^b   Blot, Philippe ^b   Vilmer, Etienne ^b   Heard, Jean Michel ^b   Péault, Bruno ^a   Lehn, Pierre ^b  

^a PSL Research University   (France)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

CD34 ANTIGEN; VIRUS VECTOR;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIGEN EXPRESSION; ARTICLE; CELL SURFACE; COMBINED IMMUNODEFICIENCY; GENE THERAPY; GENETIC TRANSDUCTION; HUMAN; HUMAN CELL; HUMAN TISSUE; LYMPHOCYTE DIFFERENTIATION; MARKER GENE; MOUSE; NONHUMAN; PREGNANCY; PRIORITY JOURNAL; RETROVIRUS; SCID MOUSE; T LYMPHOCYTE; THYMUS; UMBILICAL CORD BLOOD;

EID: 8944258557     PISSN: 00064971     EISSN: None     Source Type: Journal    
DOI: 10.1182/blood.v88.1.107.bloodjournal881107     Document Type: Article

References (25)

1. Broxmeyer HE, Douglas GW, Hangoc G, Cooper S, Bard J, English D, Arny M, Thomas L, Boyse EA: Human umbilical cord blood as a potential source of transplantable hematopoietic stem/ progenitor cells. Proc Natl Acad Sci USA 86:3828, 1989
2. Gluckman E, Broxmeyer HE, Auerbach AD, Friedman HS, Douglas GW, Devergie A, Esperou H, Thierry D, Socie G, Lehn P, Cooper S, English D, Bard J, Boyse EA: Hematopoietic reconstitution in a patient with Fanconi's anemia by means of umbilical cord blood from an HLA identical sibling. N Engl J Med 321:1174, 1989
3. Vilmer E, Sterkers G, Rahimy C, Denamur E, Elion J, Broyart A, Lescoeur B, Tiercy JM, Gerota J, Blot P: HLA-mismatched cord blood transplantation in a patient with advanced leukemia. Transplantation 53:1155, 1992
4. Moritz T, Keller DC, Williams DA: Human cord blood cells as targets for gene transfer: Potential use in genetic therapy of severe combined immunodeficiency disease. J Exp Med 178:529, 1993
5. 3+ hematopoietic stem/progenitor cells from human umbilical cord blood. J Exp Med 178:2089, 1993
6. Hanley ME, Nolta JA, Parkman R, Kohn DB: Umbilical cord blood cell transduction by retroviral vectors: Preclinical studies to optimize gene transfer. Blood Cells 20:539, 1994
7. Lu L, Xiao M, Clapp DW, Li ZH, Broxmeyer HE: Stable integration of retrovirally transduced genes into human umbilical cord blood high-proliferative potential colony-forming cells (HPP-CFC) as assessed after multiple HPP-CFC colony replatings in vitro. Blood Cells 20:525, 1994
8. + cord blood hematopoietic progenitors in the presence and absence of growth factors. Blood Cells 20:517, 1994
9. Blaese RM, Culver KW: Gene therapy for primary immunodeficiency disease. Immunodefic Rev 3:329, 1992
10. Peckham C, Gibb D: Current concepts: Mother-to-child transmission of the human immunodeficiency virus. N Engl J Med 333:298, 1995
11. Yu M, Poeschle E, Wong-Staal F: Progress towards gene therapy for HIV infection. Gene Ther 1:13, 1994
12. McCune JM, Namikawa R, Kaneshima H, Shultz LD, Lieberman M, Weissman IL: The SCID-hu mouse: Murine model for the analysis of human hematolymphoid differentiation and function. Science 241:1632, 1988
13. Péault B, Namikawa R, Krowka J, McCune JM: Experimental human hematopoiesis in immunodeficient SCID mice engrafted with fetal blood-forming organs, in Edwards RG (ed): Fetal Tissue Transplants in Medicine. Cambridge, UK, Cambridge University Press, 1992, p 77
14. Namikawa R, Weilbaecher KN, Kaneshima H, Yee EJ, McCune JM: Long-term human hematopoiesis in the SCID-hu mouse. J Exp Med 172:1055, 1990
15. + precursor cells. J Exp Med 174:1283, 1991
16. Akkina RK, Rosenblatt JD, Campbell AG, Chen IS, Zack JA: Modeling human lymphoid precursor cell gene therapy in the SCID-hu mouse. Blood 84:1393, 1994
17. Kohn DB, Weinberg KI, Nolta JA, Heiss LN, Lenarsky C, Crooks GM, Hanley ME, Annett G, Brooks JS, EI-Khoureiy A, Lawrence K, Wells S, Moen RC, Bastian J, Williams-Herman DE, Elder M, Wara D, Bowen T, Hershfield MS, Mullen CA, Blaese RM, Parkman R: Engraftment of gene-modified umbilical cord blood cells in neonates with adenosine deaminase deficiency. Nat Med 1:1017, 1995
18. Yagita H, Okumura K, Nakauchi H: Molecular cloning of the murine homologue of CD2. Homology of the molecule to its human counterpart T11. J Immunol 140:1321, 1988
19. Berenson RJ, Bensinger WI, Kalamasz D: Positive selection of viable cell populations using avidin-biotin immunoadsorption. J Immunol Methods 91:11, 1986
20. Dranoff G, Jaffee E, Lazenby A, Golumbek P, Levitsky H, Brose K, Jackson V, Hamada H, Pardoll D, Mulligan RC: Vaccination with irradiated tumor cells engineered to secrete murine granulocyte-macrophage colony-stimulating factor stimulates potent, specific, and long-lasting anti-tumor immunity. Proc Natl Acad Sci USA 90:3539, 1993
21. Danos O, Mulligan RC: Safe and efficient generation of recombinant retroviruses with amphotropic and ecotropic host ranges. Proc Natl Acad Sci USA 85:6460, 1988
22. Galy HM, Chen B: Detection of human hematopoietic stem cells in SCID-hu mice, in Namikawa R, Roncarolo MG, Péault B (eds): Human Hematopoiesis in SCID Mice. Georgetown, TX, RG Landes Co, 1995, p 15
23. 3+ human umbilical cord blood hematopoietic progenitors with high proliferative and replating potential. Blood 81:41, 1993
24. Broxmeyer HE, Hangoc G, Cooper S, Ribeiro RC, Graves V, Yoder M, Wagner J, Vadhan-Raj S, Benninger L, Rubinstein P, Broun R: Growth characteristics and expansion of human umbilical cord blood and estimation of its potential for transplantation in adults. Proc Natl Acad Sci USA 89:4109, 1992
25. Rivière I, Brose K, Mulligan RC: Effects of retroviral vector design on expression of human adenosine deaminase in murine bone marrow transplant recipients engrafted with genetically modified cells. Proc Natl Acad Sci USA 92:6733, 1995